HEB,...short interest increases,...
the question is why ?
if there is such positive sentiment of an FDA approval for their Ampligen treatment for CFS why the increased short interest ? who knows something and are they preparing for it ?
i don't have the answer just posing the inquiry.
June 19, 2009 8:24:42 AM
Hemispherx Biopharma Inc $ 2.45
Short Interest (Shares Short) 7,046,100
Days To Cover (Short Interest Ratio) 0.5
Short Percent of Float 8.50 %
Short Interest - Prior 4,990,800
Short % Increase / Decrease 41.18 %
Short Squeeze Ranking™ 10
and now,...
June 30, 2009
Hemispherx Biopharma Inc $ 2.54
Short Interest (Shares Short) 10,269,000
Days To Cover (Short Interest Ratio) 0.5
Short Percent of Float 12.39 %
Short Interest - Prior 7,046,100
Short % Increase / Decrease 45.74 %
Short Squeeze Ranking™ 14
invest at your own risk, based on your own due diligence, at your own risk tolerance